May 2004
Volume 45, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2004
Defects in RGS9 or its anchor protein R9AP in patients with bradyopsia, a novel form of retinal dysfunction
Author Affiliations & Notes
  • K. Nishiguchi
    Harvard Medical School, Massachusetts Eye and Ear Infirmary, Boston, MA
  • M.A. Sandberg
    Harvard Medical School, Massachusetts Eye and Ear Infirmary, Boston, MA
  • A.C. Kooijman
    Department of Ophthalmology, University Hospital Groningen, Groningen, The Netherlands
  • K.A. Martemyanov
    Harvard Medical School, Massachusetts Eye and Ear Infirmary, Boston, MA
  • J.W. R. Pott
    Department of Ophthalmology, University Hospital Groningen, Groningen, The Netherlands
  • S.A. Hagstrom
    Harvard Medical School, Massachusetts Eye and Ear Infirmary, Boston, MA
  • V.Y. Arshavsky
    Harvard Medical School, Massachusetts Eye and Ear Infirmary, Boston, MA
  • E.L. Berson
    Harvard Medical School, Massachusetts Eye and Ear Infirmary, Boston, MA
  • T.P. Dryja
    Harvard Medical School, Massachusetts Eye and Ear Infirmary, Boston, MA
  • Footnotes
    Commercial Relationships  K. Nishiguchi, None; M.A. Sandberg, None; A.C. Kooijman, None; K.A. Martemyanov, None; J.W.R. Pott, None; S.A. Hagstrom, None; V.Y. Arshavsky, None; E.L. Berson, None; T.P. Dryja, None.
  • Footnotes
    Support  NIH Grant EY08683, EY00169 EY12859, Foundation Fighting Blindness, American Heart Association
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 1020. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      K. Nishiguchi, M.A. Sandberg, A.C. Kooijman, K.A. Martemyanov, J.W. R. Pott, S.A. Hagstrom, V.Y. Arshavsky, E.L. Berson, T.P. Dryja; Defects in RGS9 or its anchor protein R9AP in patients with bradyopsia, a novel form of retinal dysfunction . Invest. Ophthalmol. Vis. Sci. 2004;45(13):1020.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To identify and characterize patients with mutations in the RGS9 or R9AP genes. RGS9, anchored to the disc membrane by R9AP in the rod and cone photoreceptor outer segments, accelerates the deactivation of G–proteins (transducins) in the rod and cone phototransduction cascades. The absence of RGS9 or R9AP in mice causes a substantial delay in recovery from light responses. Methods: Patients with electrophysiological characteristics suggesting a defect in phototransduction deactivation were recruited, and we sequenced their RGS9 and R9AP genes. We evaluated the patients’ acuity, color vision, contrast sensitivity, visual fields, dark–adaptation threshold, recovery of acuity after photostress, and electroretinograms (ERGs). An RGS9 mutant protein was analyzed in vitro. Results: We identified 4 index patients ages 23 to 39 who were homozygotes for a missense change (W299R) affecting a highly conserved residue in the catalytic domain of RGS9. The functional domain of RGS9 with W299R had a 20–fold reduction in its ability to promote the GTPase activity of transducin in vitro. Another index patient age 26 was homozygous for a frameshift mutation in codon 65 in the R9AP gene interpreted as a null allele. All patients complained of difficulty adapting to sudden changes in luminance levels presumably mediated by cones. Visual acuity measured with stationary letters was normal to moderately subnormal; with moving low contrast letters, acuity was reduced more than five–fold. Color vision was normal. Visual fields were normal or showed a generalized 0.3–log–unit reduction in mean sensitivity. Final dark–adaptation threshold was normal. Recovery of acuity after photostress was delayed. Full–field rod ERGs to dim blue 0.5–Hz flashes were normal. Rod–plus–cone ERGs to 0.5–Hz white flashes were normal to the first flash but markedly reduced to subsequent flashes, indicating rod dysfunction with bright flashes. Cone ERGs to 30–Hz white light showed normal initial responses but decreased to non–recordable (< 5 µV) responses in 2 seconds. After a single conditioning flash, the ERG to a second flash required about 1 minute to recover fully (normal recovery < 2 seconds). Fundus examinations were unremarkable. Ocular examinations in cluding ERGs repeatedly performed at up to a 14–year–interval showed no progression. Conclusions:Defects in RGS9 or R9AP cause a novel retinal phenotype we have termed bradyopsia.

Keywords: genetics • photoreceptors • electroretinography: clinical 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×